Last week, vaccine maker Pfizer said tests showed its Covid-19
vaccine works well in children ages 5 to 11. The vaccines these younger kids
could get would be the same as the shots teens and adults have received, but
the dose will almost certainly
be different.
Children
have different immune systems from adults. Knowing this, Pfizer tested varying
doses in its trials of children 5 to 11. Kids, it turns out, have a strong
immune response even to lower doses. So children under 12 will likely be
getting a 10-microgram dose of vaccine, compared with a 30-microgram dose for
adults.
In fact,
most adults could get by with lower doses, too, says Dr. Robert Frenck,
director of the Vaccine Research Center at Cincinnati Children's Hospital.
"We
found in 18-55-year-olds, a 10-microgram dose gives a very good immune
response," Frenck said. "But the 65 and above, they did not respond
as well to the lower doses, and so that's why we chose that 30-microgram dose,
across the adult age range from 18 to above."
Frenck
said there wasn't any time -- or any reason -- to finesse the dosing last year.
"During a pandemic, we wanted to get a vaccine out quickly," he
added.
Frenck
said so far, the Pfizer vaccine appears very safe in younger children.
"What we found is that the side effects in the children really mirrored
exactly what we saw in adults," he said.
"So the most common thing is pain at the injection site. Also having headache, and maybe fatigue. Fevers and chills were unusual -- only around 10-11% of the children having those. Similar to the adults, or identical to the adults, is that side effects lasted a day or two and then people were back to normal,” Frenck added.
No comments:
Post a Comment